Evaluation of HEArt invoLvement in Patients With FABRY Disease

Recruiting now

Conditions studied: Rare Diseases, Fabry Disease, Fabry Disease, Cardiac Variant, Hypertrophic Cardiomyopathy

In brief

This study evaluates predictors for the incidence of arrhythmias and sudden cardiac death as well as terminal heart failure in patients with Fabry disease.

Key facts

Study ID

NCT03362164

Run by

Wuerzburg University Hospital

People needed

650

Starts

2001-01-01

Expected to finish

2032-03-01

Last updated by the study team

2022-07-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Fabry disease (genetically confirmed)
• Signed informed consent
• 18 years and older

You may not qualify if…

• No informed consent
• Withdrawal of informed consent

Where it is running

• Wuerzburg University Hospital — Würzburg, Bavaria, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.